Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eunwoo Kim, Kyoung Ryun Park, In-Jin Jang, Kyung-Sang Yu & SeungHwan Lee. (2019) A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects. Drug Design, Development and Therapy 13, pages 3879-3885.
Read now
Read now
Peter Lansberg, Andre Lee, Zhen-Vin Lee, Kannan Subramaniam & Sajita Setia. (2018) Nonadherence to statins: individualized intervention strategies outside the pill box. Vascular Health and Risk Management 14, pages 91-102.
Read now
Read now
Miao Hu & Brian Tomlinson. (2014) Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 51-65.
Read now
Read now
Sydney B Long, Michael J Blaha, Roger S Blumenthal & Erin D Michos. (2011) Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clinical Interventions in Aging 6, pages 27-35.
Read now
Read now
Articles from other publishers (31)
Yujing Di, Zhaojun Wang, Chuandong Jia, Xin Xie, Shanshan Yang, Wenhua Wang, Xiaochuan Xie, Qian Wang, Chanyan Hu, Fang Xie, Mohamed Abdel-Moneim, Lionel Hovsepian, Yanzhen Wu, Na Yang & Jie Hou. (2023) A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly. Advances in Therapy 40:5, pages 2205-2216.
Crossref
Crossref
Raheleh Karimi, Ehsan Zarepur, Alireza Khosravi, Noushin Mohammadifard, Fereidoon Nouhi, Hasan Alikhasi, Shima Nasirian, Masoumeh Sadeghi, Hamidreza Roohafza, Seyed Ali Moezi Bady, Parisa janjani, Kamal Solati, Masoud Lotfizadeh, Samad Ghaffari, Elmira Javanmardi, Mahboobeh Gholipour, Mostafa dehghani, Mostafa Cheraghi, Ahmadreza Assareh, Habib Haybar, Seyedeh Mahdieh Namayandeh, Reza madadi, Javad Kojuri, Marjan Mansourian & Nizal Sarrafzadegan. (2023) Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study. International Journal of Cardiology Cardiovascular Risk and Prevention 16, pages 200168.
Crossref
Crossref
Khalifa Alrajeh & Youssef M. Roman. (2023)
The frequency of rs2231142 in
ABCG2
among Asian subgroups: implications for personalized rosuvastatin dosing
. Pharmacogenomics 24:1, pages 15-26.
Crossref
Crossref
Wilma Kiander, Noora Sjöstedt, Riikka Manninen, Liina Jaakkonen, Kati-Sisko Vellonen, Mikko Neuvonen, Mikko Niemi, Seppo Auriola & Heidi Kidron. (2022) Functional in vitro characterization of SLCO1B1 variants and simulation of the clinical pharmacokinetic impact of impaired OATP1B1 function.. European Journal of Pharmaceutical Sciences 176, pages 106246.
Crossref
Crossref
Olusola Olafuyi, Nikita Parekh, Jacob Wright & Jennifer Koenig. (2021) Inter‐ethnic differences in pharmacokinetics—is there more that unites than divides?. Pharmacology Research & Perspectives 9:6.
Crossref
Crossref
Nina Hanke, José David Gómez-Mantilla, Naoki Ishiguro, Peter Stopfer & Valerie Nock. (2021) Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions. Pharmaceutical Research 38:10, pages 1645-1661.
Crossref
Crossref
Brian Tomlinson, Chen-Hsiu Lin, Paul Chan & Christopher WK Lam. (2021) Personalized medicine in lipid-modifying therapy. Personalized Medicine 18:2, pages 185-203.
Crossref
Crossref
Perrine Courlet, Monia Guidi, Susana Alves Saldanha, Felix Stader, Anna Traytel, Matthias Cavassini, Marcel Stoeckle, Thierry Buclin, Catia Marzolini, Laurent A. Decosterd & Chantal Csajka. (2020) Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV. Clinical Pharmacokinetics 60:3, pages 379-390.
Crossref
Crossref
Tak Kyu Oh & In‐Ae Song. (2020) Prior statin therapy and 30‐day mortality in South Korean patients with acute respiratory distress syndrome. Acta Anaesthesiologica Scandinavica 65:2, pages 236-243.
Crossref
Crossref
Raju Kanukula, Abdul Salam, Anthony Rodgers & Bishoy Kamel. (2021) Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults. Clinical Pharmacokinetics 60:2, pages 165-175.
Crossref
Crossref
Daniel A. Tatosian, Ka Lai Yee, Zufei Zhang, Kate Mostoller, Erina Paul, Santosh Sutradhar, Patrick Larson, Aparna Chhibber, Jianzhong Wen, Ya‐Juan Wang, Michael Lassman, Andrew H. Latham, Jianmei Pang, Tami Crumley, Anne Gillespie, Nadia Cardillo Marricco, Ted Marenco, Matthew Murphy, Kenneth C. Lasseter, Thomas C. Marbury, Donald Tweedie, Xiaoyan Chu, Raymond Evers & S. Aubrey Stoch. (2020) A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. Clinical Pharmacology & Therapeutics 109:2, pages 403-415.
Crossref
Crossref
Clarisse Roux-Marson, Jean Baptiste Baranski, Coraline Fafin, Guillaume Exterman, Cecile Vigneau, Cecile Couchoud, Olivier Moranne & P. S. P. A. Investigators. (2020) Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatrics 20:1.
Crossref
Crossref
Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo & Hee-Jung Jee. (2019) Preadmission Statin Use and 90-day Mortality in the Critically Ill. Anesthesiology 131:2, pages 315-327.
Crossref
Crossref
Ambily Sivadas & Vinod Scaria. 2019.
119
161
.
Shelby Barnett, Kayode Ogungbenro, Karelle Ménochet, Hong Shen, Yurong Lai, W. Griffith Humphreys & Aleksandra Galetin. (2018) Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation. Clinical Pharmacology & Therapeutics 104:3, pages 564-574.
Crossref
Crossref
Hannah H. Lee & Richard H. Ho. (2017)
Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1;
SLCO1B1
)
. British Journal of Clinical Pharmacology 83:6, pages 1176-1184.
Crossref
Crossref
Bhagwat Prasad, Marc Vrana, Aanchal Mehrotra, Katherine Johnson & Deepak Kumar Bhatt. (2017) The Promises of Quantitative Proteomics in Precision Medicine. Journal of Pharmaceutical Sciences 106:3, pages 738-744.
Crossref
Crossref
Ryo Naito, Katsumi Miyauchi & Hiroyuki Daida. (2017) Racial Differences in the Cholesterol-Lowering Effect of Statin. Journal of Atherosclerosis and Thrombosis 24:1, pages 19-25.
Crossref
Crossref
Wan-Su ParkDooyeon JangSeunghoon HanDong-Seok Yim. (2016) Mixed–effects analysis of increased rosuvastatin absorption by coadministered telmisartan. Translational and Clinical Pharmacology 24:1, pages 55.
Crossref
Crossref
Merran Macpherson, Bengt Hamrén, Marjet J. A. M. Braamskamp, John J. P. Kastelein, Torbjörn Lundström & Paul D. Martin. (2015) Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia. European Journal of Clinical Pharmacology 72:1, pages 19-27.
Crossref
Crossref
Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby, Connie T. Azumaya, Cheryl Wei, Yusong Chen, Rogelio Mosqueda-Garcia & Helen J. Ambrose. (2015) Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?. European Journal of Clinical Pharmacology 71:3, pages 341-355.
Crossref
Crossref
Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby, Connie T. Azumaya, Julie Zalikowski, Yusong Chen, Kenneth Kim & Helen J. Ambrose. (2015) Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States. European Journal of Clinical Pharmacology 71:3, pages 329-340.
Crossref
Crossref
Hon-Kit Lee, Miao Hu, Sandra SH Lui, Chung-Shun Ho, Chun-Kwok Wong & Brian Tomlinson. (2013)
Effects of polymorphisms in
ABCG2
,
SLCO1B1
,
SLC10A1
and
CYP2C9
/
19
on plasma concentrations of rosuvastatin and lipid response in Chinese patients
. Pharmacogenomics 14:11, pages 1283-1294.
Crossref
Crossref
Nathan W. Brunner, Krishnan Ramanathan, Hong Wang, Hude Quan & Nadia A. Khan. (2013) Effectiveness of Statin Prescribing on Reducing Mortality in South Asian, Chinese, and White Patients With Diabetes. Canadian Journal of Cardiology 29:8, pages 920-926.
Crossref
Crossref
Bruce K. Birmingham, Suzanne K. Swan, Tom Puchalski, Pat Mitchell, Connie Azumaya, Julie Zalikowski & Yi Wang. (2013) Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis. Clinical Drug Investigation 33:4, pages 233-241.
Crossref
Crossref
Ping Wang. (2011) Statin dose in Asians: is pharmacogenetics relevant?. Pharmacogenomics 12:11, pages 1605-1615.
Crossref
Crossref
Ana Moreno, Jesús Fortún, Javier Graus, Miguel A. Rodriguez-Gandía, Carmen Quereda, María J. Pérez-Elías, Javier Nuño, Philip Wikman, Santiago Moreno & Rafael Bárcena. (2011) Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia. Liver Transplantation 17:3, pages 331-333.
Crossref
Crossref
Juan Yang, Lu-jin Li, Kun Wang, Ying-chun He, Yu-cheng Sheng, Ling Xu, Xiao-hui Huang, Feng Guo & Qing-shan Zheng. (2010) Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients. Acta Pharmacologica Sinica 32:1, pages 116-125.
Crossref
Crossref
Xue-Ning Li, Hong-Rong Xu, Wei-Li Chen, Nan-Nan Chu & Jun-Ren Zhu. (2010) Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: A randomized, open-label, ascending single- and multiple-dose study. Clinical Therapeutics 32:3, pages 575-587.
Crossref
Crossref
Takahiko Aoyama, Takayuki Omori, Satoshi Watabe, Akemi Shioya, Takahiro Ueno, Noboru Fukuda & Yoshiaki Matsumoto. (2010) Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Rosuvastatin Using an Extension of the Indirect Response Model by Incorporating a Circadian Rhythm. Biological and Pharmaceutical Bulletin 33:6, pages 1082-1087.
Crossref
Crossref
Roger K. Verbeeck & Flora T. Musuamba. (2009) Pharmacokinetics and dosage adjustment in patients with renal dysfunction. European Journal of Clinical Pharmacology 65:8, pages 757-773.
Crossref
Crossref